Prashant Jani

966 total citations
23 papers, 498 citations indexed

About

Prashant Jani is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Prashant Jani has authored 23 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 10 papers in Pathology and Forensic Medicine and 8 papers in Oncology. Recurrent topics in Prashant Jani's work include Breast Cancer Treatment Studies (11 papers), Global Cancer Incidence and Screening (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Prashant Jani is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Global Cancer Incidence and Screening (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Prashant Jani collaborates with scholars based in Canada and United States. Prashant Jani's co-authors include Stefano Serra, Eileen Rakovitch, Wedad Hanna, Sandip Sengupta, Leela Elavathil, Alan B. Tuck, Sachiko T. St. Jeor, Susan J. Done, Diane Chau and Sharon Nofech‐Mozes and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Prashant Jani

22 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prashant Jani Canada 12 259 209 147 110 63 23 498
Emmy Ludwig United States 11 211 0.8× 74 0.4× 429 2.9× 234 2.1× 157 2.5× 32 682
Rula C. Geha United States 10 184 0.7× 103 0.5× 130 0.9× 189 1.7× 52 0.8× 12 451
Johan Eide Norway 12 261 1.0× 89 0.4× 234 1.6× 96 0.9× 72 1.1× 22 686
Jung‐Sun Kim South Korea 13 112 0.4× 122 0.6× 157 1.1× 290 2.6× 52 0.8× 18 948
H. Jouhadi Morocco 12 83 0.3× 89 0.4× 215 1.5× 94 0.9× 62 1.0× 92 472
Jula Veerapong United States 12 95 0.4× 120 0.6× 211 1.4× 165 1.5× 75 1.2× 45 513
Matthew E. Witek United States 14 52 0.2× 72 0.3× 214 1.5× 177 1.6× 81 1.3× 50 578
Takachika Ozawa Japan 13 44 0.2× 105 0.5× 118 0.8× 135 1.2× 45 0.7× 28 417
Errol L. Berman United States 11 50 0.2× 106 0.5× 178 1.2× 75 0.7× 64 1.0× 15 435
Ioannis G. Panayiotides Greece 13 43 0.2× 71 0.3× 245 1.7× 106 1.0× 64 1.0× 42 463

Countries citing papers authored by Prashant Jani

Since Specialization
Citations

This map shows the geographic impact of Prashant Jani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prashant Jani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prashant Jani more than expected).

Fields of papers citing papers by Prashant Jani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prashant Jani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prashant Jani. The network helps show where Prashant Jani may publish in the future.

Co-authorship network of co-authors of Prashant Jani

This figure shows the co-authorship network connecting the top 25 collaborators of Prashant Jani. A scholar is included among the top collaborators of Prashant Jani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prashant Jani. Prashant Jani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Omstead, Ashten N., et al.. (2022). Tumor Microenvironment before and after Chemoradiation in Locally Advanced Rectal Cancer: Beyond PD-L1. Cancers. 15(1). 276–276. 6 indexed citations
2.
Shaikh, Hira, et al.. (2018). Mantle Cell Lymphoma Relapsing as Disease of Skin, Orbit and CNS: An Extremely Rare Presentation and a Review of Literature. Journal of Hematology. 7(1). 38–42. 3 indexed citations
3.
Jani, Prashant, Daniel J. Lee, Amy Tang, et al.. (2018). Fludarabine, Busulfan and TBI Based Conditioning for Autologous and Allogeneic HCT for T-Cell Malignancy. Biology of Blood and Marrow Transplantation. 24(3). S177–S178.
4.
Rakovitch, Eileen, Sharon Nofech‐Mozes, Wedad Hanna, et al.. (2017). Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy. The Breast. 37. 181–186. 14 indexed citations
5.
Rakovitch, Eileen, Sharon Nofech‐Mozes, Wedad Hanna, et al.. (2016). Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ. JNCI Journal of the National Cancer Institute. 109(4). djw256–djw256. 66 indexed citations
6.
7.
Rakovitch, Eileen, Steven Shak, Dave P. Miller, et al.. (2015). A Large Prospectively Designed Study of the DCIS Score: Recurrence Risk After Local Excision For Ductal Carcinoma In Situ Patients With and Without Irradiation. International Journal of Radiation Oncology*Biology*Physics. 93(3). S135–S136. 3 indexed citations
8.
Rakovitch, Eileen, Sharon Nofech‐Mozes, Wedad Hanna, et al.. (2015). Correlation between the DCIS Score and traditional clinicopathologic features in the prospectively-designed Ontario population-based validation study.. Journal of Clinical Oncology. 33(15_suppl). 581–581. 1 indexed citations
9.
Lalani, Nafisha, Lawrence Paszat, Rinku Sutradhar, et al.. (2014). Long-term Outcomes of Hypofractionation Versus Conventional Radiation Therapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ of the Breast. International Journal of Radiation Oncology*Biology*Physics. 90(5). 1017–1024. 46 indexed citations
10.
11.
Rakovitch, Eileen, Steven A. Narod, Wedad Hanna, et al.. (2013). Impact of Boost Radiation in the Treatment of Ductal Carcinoma In Situ: A Population-Based Analysis. International Journal of Radiation Oncology*Biology*Physics. 86(3). 491–497. 28 indexed citations
12.
Rakovitch, Eileen, Sharon Nofech‐Mozes, Steven A. Narod, et al.. (2013). Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis. Breast Cancer Research and Treatment. 138(2). 581–590. 52 indexed citations
13.
14.
Jani, Prashant, et al.. (2009). Massive bone marrow involvement by clear cell variant of rhabdomyosarcoma. The Indian Journal of Pediatrics. 76(2). 224–228. 6 indexed citations
15.
Chang, Hong, Connie Qi, Young Trieu, et al.. (2009). Prognostic Relevance of 6q Deletion in Waldenström's Macroglobulinemia: A Multicenter Study. Clinical Lymphoma & Myeloma. 9(1). 36–38. 32 indexed citations
16.
Jani, Prashant, Runjan Chetty, & Danny Ghazarian. (2008). An Unusual Composite Pilomatrix Carcinoma With Intralesional Melanocytes: Differential Diagnosis, Immunohistochemical Evaluation, and Review of the Literature. American Journal of Dermatopathology. 30(2). 174–177. 33 indexed citations
17.
Chau, Diane, et al.. (2008). Individualizing recommendations for weight management in the elderly. Current Opinion in Clinical Nutrition & Metabolic Care. 11(1). 27–31. 46 indexed citations
18.
Jani, Prashant, Ahmed Nasr, & Dina El Demellawy. (2008). Synchronous renal cell carcinoma and adrenocortical carcinoma: a rare case report and clinicopathologic approach.. PubMed. 15(2). 4016–9. 8 indexed citations
19.
Jani, Prashant, Qi Xiao, & Hong Chang. (2006). Aberrant expression of T‐cell‐associated markers CD4 and CD7 on B‐cell chronic lymphocytic leukemia. American Journal of Hematology. 82(1). 73–76. 13 indexed citations
20.
Serra, Stefano & Prashant Jani. (2006). An approach to duodenal biopsies. Journal of Clinical Pathology. 59(11). 1133–1150. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emmy Ludwig Breakdown of academic impact, for papers by Rula C. Geha Breakdown of academic impact, for papers by Johan Eide Breakdown of academic impact, for papers by Jung‐Sun Kim Breakdown of academic impact, for papers by H. Jouhadi Breakdown of academic impact, for papers by Jula Veerapong Breakdown of academic impact, for papers by Matthew E. Witek Breakdown of academic impact, for papers by Takachika Ozawa Breakdown of academic impact, for papers by Errol L. Berman Breakdown of academic impact, for papers by Ioannis G. Panayiotides
Rankless by CCL
2026